Pfizer Shares Rise on RBC Upgrade and Regulatory Updates

SentiSense · Published · Updated

Pfizer's stock price increased after receiving a positive RBC upgrade and news about its US labeling for the medicine HYMPAVZI. Investors are digestin...

Sign in to read the full story. Free accounts include 20 full reads a month.

Sign in or create a free account

Powered by SentiSense - Intelligent Market Analysis